Cambridge Investment Research Advisors, Inc. Lannett CO Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020
SELL
$6.36 - $10.05 $80,682 - $127,494
-12,686 Closed
0 $0
Q4 2019

Feb 04, 2020
BUY
$8.49 - $12.81 $107,704 - $162,507
12,686 New
12,686 $111,000
Q2 2019

Aug 15, 2019
SELL
$5.22 - $9.08 $500,420 - $870,463
-95,866 Closed
0 $0
Q1 2019

May 08, 2019
BUY
$5.35 - $9.82 $512,883 - $941,404
95,866 New
95,866 $0

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About LANNETT CO INC

LCI Quotes by TradingView
  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email